Mucus Relief Cough And Congestion Dm Tablet
NDC Package 17714-150-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mucus Relief Cough And Congestion Dm (guaifenesin and dextromethorphan hbr) tablets is take with a full glass of wateradults and children 12 years of age and over: 1 tablet every 4 hours. This formulation utilizes a tablet delivery system. Marketed by Advance Pharmaceutical Inc., this product is identified by NDC 17714-150 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
17714-150-60
Package Description
60 TABLET in 1 BOTTLE
Product Code
17714-150
11-Digit Billing Format
17714015060
RxNorm Crosswalk
  • RxCUI: 1147685 - dextromethorphan HBr 20 MG / guaiFENesin 400 MG Oral Tablet
  • RxCUI: 1147685 - dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Oral Tablet
  • RxCUI: 1147685 - guaifenesin 400 MG / dextromethorphan HBr 20 MG Oral Tablet

Clinical Specifications

Proprietary Name
Mucus Relief Cough And Congestion Dm
Non-Proprietary Name
Guaifenesin And Dextromethorphan Hbr
Substance Name
Dextromethorphan Hydrobromide; Guaifenesin
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Take with a full glass of wateradults and children 12 years of age and over: 1 tablet every 4 hours. Do not take more than 6 tablets in 24 hours. children under 12 years: do not use

Regulatory & Marketing

Labeler Name
Advance Pharmaceutical Inc.
Product Type
Human Otc Drug
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-01-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17714-150-60 identifies a specific commercial package of 60 tablet in 1 bottle of Mucus Relief Cough And Congestion Dm, a human over the counter drug labeled by Advance Pharmaceutical Inc.. This tablet is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advance Pharmaceutical Inc. on August 01, 2017. The current certification is valid through December 31, 2026.

How is this Advance Pharmaceutical Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17714015060. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17714-150-60
11-Digit CMS (5-4-2)
17714-0150-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.